Adding the immune component in reconstructed human skin and eye epithelia models
2018
Poster Asiatox | EPISKIN Academy, Lyon, France - DBV Technologies, Bagneux, France - Vitroscreen, Milan, Italy - GSK, Les ullis, France
Cellular mechanistic investigation on antigen delivery by Viaskin® patchfor epicutaneous immunotherapy with reconstructed human epidermisincluding Langerhans cells (SkinEthicTM RHE-LC)
2018
Poster | DBV Technologies, Montrouge, France - Episkin, Lyon, France
Safety Assessment of Botanicals: A Decision Tree Approach for the Safety Assessment of Botanical Cosmetic Ingredients
2012
SOT Society of Toxicology annual meeting | L'Oréal, Research & Innovation
L’Oréal commitment in the develo pment, evaluation and validation of screening and testing approaches contributing to the 3Rs
2011
| L'Oréal
Transcriptional profiling defines the effects of nickel in human epidermal keratinocytes.
2008
| SkinEthic
Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis
2008
Microbiology | St Thomas's Hospital, University of Tuebingen, Friedrich Schiller University Jena and Department of Microbial Pathogenicity Mechanisms
Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro.
2007
Journal of Cosmetic Dermatology | Procter & Gamble
Development of genotoxicity test procedures with Episkin®, a reconstructed human skin model: Towards new tools for in vitro risk assessment of dermally applied compounds?
2006
Mutation Research/Genetic Toxicology and Environmental Mutagenesis Volume 606, Issues 1-2, 14 July 2006, Pages 39-51 | L’Oréal, Advanced Research, Life Sciences, Safety Research Department, Phototoxicity-Genotoxicity-Carcinogenicity Group, 1, avenue E. Schueller, F-93600 Aulnay Sous Bois, France
Alternatives to animal testing: research, trends, validation, regulatory acceptance
2003
ALTEX 2003 ;20 (Suppl 1):3-61 | Toxicology Consulting Services, Plainsboro, USA.
Currently available in vitro methods used in the regulatory toxicology
2002
Toxicol Lett 2002 Feb 28 ;127 (1-3):127-34 | National Centre for Documentation and Evaluation of Alternative Methods to Animal Experiments (ZEBET), Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV), Diedersdorfer Weg 1, D-12277 Berlin, Germany. [email protected]
The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products
2002
Toxicol Lett 2002 Feb 28 ;127 (1-3):177-82 | Health and Safety Executive, Magdalen House, Stanley Precinct, Bootle, Merseyside L20 3QZ, UK. [email protected]
Temporal Expression of the Candida albicans Genes CHK1 and CSSK1, Adherence, and Morphogenesis in a Model of Reconstituted Human Esophageal Epithelial Candidiasis
2002
Georgetown University Medical Center and Universitätsklinik fur Chirurgie |
Industry experience with alternative methods
1998
Toxicol Lett 1998 Dec 28 ;102-103):575-9 | Life Sciences-L'OREAL Advanced Research, Clichy, France.
The use of a reconstructed human epidermis episkin for the assessment of safety and efficacy of cosmetic products
1995
In Vitro Toxicology: Journal of Molecular and Cellular Toxicology 1995 ;8 (4):427-429 | L'OREAL, Basic Research Center, 1 av E Schueller,93600 Aulnay-sous-Bois